Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06302465
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2024-02-25
Brief Title:
Narlumosbartmab Combined With Neoadjuvant Chemotherapy in Bone-derived Malignancies With Osteolytic Lesions and Multinucleated Giant Cells
Sponsor:
Organization:
Peking University Peoples Hospital